This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)
C3_TONSIL_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
585 |
4. Check minimum number of eventsNone |
585 |
5. Include endpointsNone |
585 |
6. Filter based on genotype QC (FinnGen only) |
585 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 585 | 181 | 404 |
| Unadjusted period prevalence (%) | 0.14 | 0.06 | 0.18 |
| Median age at first event (years) | 61.77 | 62.46 | 61.46 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 447
- Matched controls
- 4470
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C09.0
ICD-10 Finland
Malignant neoplasm: Tonsillar fossa
+∞
268.8
230
*
8070/3-C09.9
ICD-O-3
Squamous cell carcinoma, NOS, of tonsil, NOS
+∞
268.8
230
*
130
Kela drug reimbursment
Malignant tumour
+∞
267.4
229
*
A03FA01
ATC
metoclopramide; systemic, rectal
30.9
191.8
282
234
C09.9
ICD-10 Finland
Malignant neoplasm: Tonsil, unspecified
+∞
180.9
161
*
WF002
NOMESCO Finland
Radical radiotherapy
1210.3
173.2
158
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
178.6
161.0
161
14
EMB10
NOMESCO Finland
Tonsillectomy
45.9
149.0
184
67
JDB10
NOMESCO Finland
Percutaneous gastrostomy
155.5
144.6
147
14
A04AA02
ATC
granisetron; systemic, transdermal
+∞
132.0
120
*
H02AB02
ATC
dexamethasone; systemic
194.1
125.8
126
9
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
1416.6
116.1
108
*
N02AA05
ATC
oxycodone; systemic
14.1
101.5
193
228
C09.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of tonsil
+∞
100.9
93
*
A04AA01
ATC
ondansetron; systemic, rectal
71.5
100.3
113
21
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
556.6
94.0
90
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
91.9
85
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
27.7
90.8
127
63
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
84.3
89.9
99
15
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
33.6
84.9
112
44
EMA10
NOMESCO Finland
Biopsy of tonsil
246.4
81.2
81
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
7.5
80.1
254
670
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
78.5
73
*
XX3DW
NOMESCO Finland
Time consuming IT work
19.0
73.1
116
81
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
72.9
68
*
D10.4
ICD-10 Finland
Benign neoplasm: Tonsil
176.7
72.4
74
5
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
71.8
67
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
70.7
66
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
70.7
66
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
61.9
58
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
25.7
60.8
86
41
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
661.7
60.2
58
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
33.6
58.1
76
27
UJC01
NOMESCO Finland
Scopy of lower throat
138.2
57.4
60
5
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
56.5
53
*
8070/3-C09.0
ICD-O-3
Squamous cell carcinoma, NOS, of tonsillar fossa
+∞
55.4
52
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
57.2
54.7
64
13
R4190
NOMESCO Finland
Nutritional therapy
26.7
54.5
76
34
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
76.7
53.7
60
9
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
558.4
51.5
50
*
9680/3-C09.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of tonsil, NOS
+∞
51.0
48
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
46.7
44
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
45.6
43
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
80.0
45.0
50
7
JN4BD
NOMESCO Finland
Extensive body CT
10.6
44.6
91
105
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
127.8
43.6
46
*
A07AA02
ATC
nystatin; oral
10.0
42.7
90
110
A04AD12
ATC
aprepitant; systemic
+∞
40.2
38
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.9
40.0
263
1206
L03AA02
ATC
filgrastim; parenteral
422.7
39.7
39
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
150.0
39.4
41
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
39.1
37
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
410.7
38.7
38
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
59.2
37.1
43
8
L03AA13
ATC
pegfilgrastim; parenteral
+∞
37.0
35
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.1
37.0
185
656
UDH02
NOMESCO Finland
Rhinopharyngoscopy
8.3
36.9
87
127
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
201.1
36.3
37
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
8.4
36.1
84
120
SAA03
NOMESCO Finland
Extended examination of mouth
3.7
35.9
234
1033
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
9.6
35.7
76
93
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
195.2
35.3
36
*
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
351.7
33.3
33
*
9591/3-C09.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of tonsil, NOS
+∞
32.7
31
*
J35.1
ICD-10 Finland
Hypertrophy of tonsils
47.3
32.4
39
9
EBA15
NOMESCO Finland
Extraction of large number of teeth
9.7
31.8
67
80
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
91.8
31.2
34
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
8.8
30.1
67
88
GBB00
NOMESCO Finland
Tracheostomy
30.4
29.4
39
14
WW500
NOMESCO Finland
Blood transfusion
15.1
29.3
49
36
WZC30
NOMESCO Finland
Teaching
5.0
29.1
103
252
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
17.0
28.8
46
30
A04AA55
ATC
palonosetron, combinations; systemic
+∞
28.4
27
*
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
66.4
27.3
31
5
Z51.5
ICD-10 Finland
Palliative care
13.3
27.2
48
40
EBA10
NOMESCO Finland
Surgical removal of tooth
5.2
26.9
90
205
C61
ICD-10 Finland
Malignant neoplasm of prostate
143.3
25.9
27
*
ENB20
NOMESCO Finland
Pharyngectomy
+∞
25.2
24
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
25.2
24
*
JN6AD
NOMESCO Finland
CT of torso and neck
51.5
24.6
29
6
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
24.2
23
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
252.9
23.9
24
*
R13
ICD-10 Finland
Dysphagia
5.9
23.7
70
137
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.7
23.5
71
143
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
5.3
23.2
75
163
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
4.4
23.1
92
250
D70.82
ICD-10 Finland
Drug-induced neutropenia
55.0
22.3
26
5
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
230.8
21.8
22
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
7.2
21.6
54
84
WX402
NOMESCO Finland
General anaesthesia
3.8
21.6
101
316
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
21.0
20
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
21.0
20
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
219.8
20.8
21
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
219.8
20.8
21
*
K11.70
ICD-10 Finland
Hypoptyalism
50.5
20.4
24
5
ZX120
NOMESCO Finland
Intravenous
5.1
20.1
67
150
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
20.1
240
1391
ENA10
NOMESCO Finland
Biopsy of pharynx
60.4
20.1
23
*
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
+∞
19.9
19
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
19.9
19
*
UJC02
NOMESCO Finland
Rigid oesophagoscopy
26.0
19.8
27
11
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
208.8
19.7
20
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
12.6
19.6
35
30
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
57.7
19.1
22
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
18.9
18
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
18.9
18
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
18.9
18
*
SCA04
NOMESCO Finland
Guidance on care of mouth and oral mucosa
197.9
18.7
19
*
XW000
NOMESCO Finland
Bone marrow biopsy
8.9
18.7
40
49
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
6.1
18.5
52
95
SBB10
NOMESCO Finland
Teeth copy
6.1
18.0
50
90
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
69.5
17.9
20
*
A06AD11
ATC
lactulose; oral
3.4
17.3
93
320
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.2
17.2
47
83
9673/3-C09.9
ICD-O-3
Mantle cell lymphoma of tonsil, NOS
+∞
16.8
16
*
H03AA01
ATC
levothyroxine sodium; systemic
2.9
16.7
122
518
GD1AD
NOMESCO Finland
Thorax CT examination
6.3
16.7
45
78
WX110
NOMESCO Finland
Local anesthesy
2.4
16.4
309
2164
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
4.3
15.9
62
163
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
15.7
15
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
15.7
15
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
15.7
15
*
R07.0
ICD-10 Finland
Pain in throat
5.0
15.6
51
112
WX002
NOMESCO Finland
Sedation and analgesia
2.8
15.5
118
512
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.7
15.3
71
217
JN4AD
NOMESCO Finland
Body CT examination
6.5
15.2
40
67
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
58.7
14.9
17
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
58.7
14.9
17
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.4
14.8
150
764
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
+∞
14.7
14
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
14.7
14
*
EMB00
NOMESCO Finland
Excision of lesion of tonsil or adenoids
+∞
14.7
14
*
C09
ICD-10 Finland
Malignant neoplasm of tonsil
+∞
14.7
14
*
ENB00
NOMESCO Finland
Excision or exploration of lesion of pharynx
82.9
14.7
16
*
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
154.8
14.5
15
*
SCA03
NOMESCO Finland
Preventive oral health care, extensive
7.1
14.3
35
53
TJD20
NOMESCO Finland
Change of gastrostomy tube
44.0
14.2
17
*
RD210
NOMESCO Finland
NA
15.4
13.7
22
15
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
13.6
13
*
RD160
NOMESCO Finland
NA
144.2
13.5
14
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
22.0
13.4
19
9
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.9
13.3
56
157
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
13.0
98
419
EB1WA
NOMESCO Finland
NA
23.4
13.0
18
8
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
71.9
12.7
14
*
115
Kela drug reimbursment
Breast cancer
+∞
12.6
12
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
12.6
12
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
12.6
12
*
C09.1
ICD-10 Finland
Malignant neoplasm: Tonsillar pillar (anterior)(posterior)
+∞
12.6
12
*
A02BC05
ATC
esomeprazole; systemic
2.1
12.5
205
1282
K05.31
ICD-10 Finland
Periodontitis pronounced
3.0
12.2
76
287
T05
ICPC
Feeding problem of adult
27.6
12.1
16
6
UDQ22
NOMESCO Finland
Microlaryngoscopy
22.0
12.1
17
8
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
8.5
11.7
25
31
SAA04
NOMESCO Finland
Special inverstigation of mouth
4.3
11.7
43
107
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
10.5
11.6
22
22
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
6.4
11.6
30
50
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
11.5
11
*
Z43.1
ICD-10 Finland
Attention to gastrostomy
123.0
11.5
12
*
PJA12
NOMESCO Finland
Sentinel node biopsy
123.0
11.5
12
*
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
11.6
11.1
20
18
R4110
NOMESCO Finland
Physiotherapy
2.2
11.1
126
664
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
11.0
146
821
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
11.0
107
520
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
6.8
11.0
27
42
ENB40
NOMESCO Finland
Excision of branchial cyst or fistula
28.8
10.8
14
5
J02AC01
ATC
fluconazole; systemic
2.1
10.7
150
863
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.1
10.5
59
207
A02BC02
ATC
pantoprazole; systemic
2.0
10.5
294
2206
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
112.5
10.5
11
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
10.5
10
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
10.5
10
*
SXC03
NOMESCO Finland
Other oral or dental procedure
12.4
10.4
18
15
EBA12
NOMESCO Finland
Complicated surgical removal of tooth
9.1
10.4
21
24
Q18.0
ICD-10 Finland
Sinus, fistula and cyst of branchial cleft
33.4
10.4
13
*
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
5.1
10.3
32
67
B01AB10
ATC
tinzaparin; parenteral
4.6
10.3
35
81
K05.30
ICD-10 Finland
Periodontitis complex
2.6
10.0
75
318
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
26.7
9.9
13
5
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
20.6
9.9
14
7
ENB99
NOMESCO Finland
Other excision of pharynx and adjacent structures
56.2
9.7
11
*
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
15.5
9.6
15
10
SBA00
NOMESCO Finland
Microbiological examinations
6.4
9.5
24
39
D37.09
ICD-10 Finland
Lip, oral cavity and pharynx
102.1
9.4
10
*
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
102.1
9.4
10
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
9.4
9
*
8085/3-C09.9
ICD-O-3
Squamous cell carcinoma, HPV positive of tonsil, NOS
+∞
9.4
9
*
UJC20
NOMESCO Finland
Extensive endoscopy to identify diagnosed or suspected primary malignant neoplasm of head or neck
+∞
9.4
9
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
9.4
9
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
L01BC06
ATC
capecitabine; oral
+∞
9.4
9
*
1460A
ICD-9 Finland
Malignant neoplasm of oropharynx, Tonsil
+∞
9.4
9
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
9.4
9
*
ZX112
NOMESCO Finland
Subcutaneous
14.1
9.2
15
11
UDQ02
NOMESCO Finland
Direct laryngoscopy
16.0
9.1
14
9
ED1AA
NOMESCO Finland
Mandipular X-ray examination
16.0
9.1
14
9
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.1
9.0
121
678
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
19.1
9.0
13
7
1XC02
NOMESCO Finland
NA
24.6
8.9
12
5
K02.1
ICD-10 Finland
Caries of dentine
1.8
8.9
244
1770
B01AB05
ATC
enoxaparin; parenteral
2.0
8.8
131
764
J01MA12
ATC
levofloxacin; systemic
2.2
8.7
93
469
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
51.0
8.7
10
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
51.0
8.7
10
*
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
16.7
8.6
13
8
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
3.4
8.5
41
130
EHA10
NOMESCO Finland
Biopsy of palate
28.1
8.5
11
*
J35.9
ICD-10 Finland
Chronic disease of tonsils and adenoids, unspecified
91.7
8.4
9
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.7
8.4
36
104
N05CF01
ATC
zopiclone; oral
1.9
8.4
148
918
116
Kela drug reimbursment
Prostate cancer
+∞
8.4
8
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
8.4
8
*
A79
ICPC
Malignancy NOS
+∞
8.4
8
*
K10.26
ICD-10 Finland
Periostitis of jaw (acute)(chronic)(suppurative)
+∞
8.4
8
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
8.4
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
8.4
8
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
8.4
8
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
8.4
8
*
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
3.6
8.3
37
110
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
3.5
8.3
38
116
R50.9
ICD-10 Finland
Fever, unspecified
2.5
8.3
68
303
JN4DR
NOMESCO Finland
Whole body metabolic PET with CT
34.0
8.1
10
*
EBB15
NOMESCO Finland
Insertion of dental implant abutment
13.3
7.9
13
10
SBA10
NOMESCO Finland
Measurement of excretion of saliva
15.4
7.8
12
8
EBA00
NOMESCO Finland
Extraction of tooth
1.9
7.7
153
981
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
2.0
7.7
110
625
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
7.7
174
1167
UJC12
NOMESCO Finland
Flexible oesophagoscopy
18.7
7.6
11
6
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
25.5
7.6
10
*
K08.3
ICD-10 Finland
Retained dental root
2.8
7.5
47
178
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
81.4
7.4
8
*
UGC02
NOMESCO Finland
Rigid bronchoscopy
81.4
7.4
8
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
81.4
7.4
8
*
ZX080
NOMESCO Finland
Image guided radiotherapy
81.4
7.4
8
*
WX199
NOMESCO Finland
Other local analgesia
4.9
7.4
23
49
M04AA01
ATC
allopurinol; systemic
2.2
7.4
74
363
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
7.0
7.4
17
25
ZZA00
NOMESCO Finland
Split skin graft
5.3
7.3
21
41
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
7.3
7
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
7.3
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.3
7
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
7.3
7
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.6
7.3
20
37
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.8
7.3
46
176
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.5
7.2
58
253
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
5.2
7.2
21
42
EBB10
NOMESCO Finland
Insertion of dental implant
9.0
7.1
14
16
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
10.3
7.1
13
13
J01DB01
ATC
cefalexin; oral
1.9
7.0
353
2993
R4130
NOMESCO Finland
Speech therapy
5.3
7.0
20
39
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
6.5
7.0
17
27
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
6.9
57
254
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
14.1
6.9
11
8
R11
ICD-10 Finland
Nausea and vomiting
3.0
6.8
37
129
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.8
6.8
18
32
TPH07
NOMESCO Finland
Cathetrisation of artery
2.5
6.8
53
228
SDA02
NOMESCO Finland
Parodonthologic therapy
1.8
6.8
137
877
N02BE01
ATC
paracetamol; systemic, rectal
1.9
6.7
367
3166
K11.2
ICD-10 Finland
Sialoadenitis
4.4
6.7
23
55
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
22.9
6.7
9
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
6.7
112
673
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
8.9
6.6
13
15
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
4.6
6.6
21
47
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
70.8
6.4
7
*
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
6.1
6.4
16
27
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
9.4
6.3
12
13
K12.10
ICD-10 Finland
Stomatitis NOS
18.3
6.3
9
5
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
6.3
6
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
6.3
6
*
EP1DM
NOMESCO Finland
Very extensive MRI examination of soft tissue of neck with 3 Tesla magnet
+∞
6.3
6
*
8083/3-C09.9
ICD-O-3
Basaloid squamous cell carcinoma of tonsil, NOS
+∞
6.3
6
*
WW402
NOMESCO Finland
Leucoferesis
+∞
6.3
6
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
QA9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head or neck, unspecified
+∞
6.3
6
*
9691/3-C09.9
ICD-O-3
Follicular lymphoma, grade 2 of tonsil, NOS
+∞
6.3
6
*
JDB00
NOMESCO Finland
Gastrostomy
+∞
6.3
6
*
C04.0
ICD-10 Finland
Malignant neoplasm: Anterior floor of mouth
+∞
6.3
6
*
8072/3-C09.9
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of tonsil, NOS
+∞
6.3
6
*
J01CE02
ATC
phenoxymethylpenicillin; oral
1.7
6.1
289
2346
A01AB10
ATC
natamycin; local oral
5.3
6.1
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
274
148
33.94
307.65
1.5
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
115
59
24.02
152.66
1.4
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
283
678
7.15
123.86
7.4
2.8
mmol/l
0.8
0.8
16.77
276
631
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
125
122
12.76
116.65
3.6
2.5
mg/l
1.1
1.6
6.70
125
108
(40768804) Tissue Pathology biopsy report
371
1355
5.75
96.32
2.6
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
47
13
39.22
75.84
1.1
1.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
317
1383
3.82
56.40
5.8
2.1
mmol/l
2.4
2.3
2.18
300
1154
(3013650) Neutrophils [#/volume] in Blood by Automated count
442
2431
4.35
55.02
14.5
6.8
e9/l
4.0
4.3
1.64
401
2129
(3002256) Pathology report gross observation
128
333
4.64
46.23
1.4
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
396
2232
3.40
42.68
9.6
4.1
umol/l
10.2
12.6
5.21
389
2109
(3024561) Albumin [Mass/volume] in Serum or Plasma
350
1908
3.08
38.51
6.5
3.9
g/l
35.2
35.8
1.35
334
1763
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
348
1954
2.93
35.15
4.6
3.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
226
1039
2.91
32.75
10.9
4.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
258
1273
2.84
32.71
3.0
2.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
281
1463
2.77
31.91
6.0
5.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
338
1990
2.65
29.17
7.1
5.7
%
0.6
0.7
1.54
318
1859
(3006504) Eosinophils/100 leukocytes in Blood
342
2057
2.60
27.74
7.1
5.8
%
2.8
3.1
1.64
323
1918
(3019069) Monocytes/100 leukocytes in Blood
341
2064
2.56
27.05
7.4
6.1
%
9.6
8.9
2.85
323
1931
(3002030) Lymphocytes/100 leukocytes in Blood
344
2103
2.54
26.52
7.4
5.9
%
23.8
27.5
6.97
323
1962
(3021879) Hepatitis B virus core Ab [Presence] in Serum
84
240
3.92
26.07
1.3
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
34
42
8.53
25.87
1.4
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
353
2204
2.52
25.70
6.9
5.6
e9/l
0.6
0.6
0.16
311
1918
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
179
811
2.74
25.70
4.8
2.1
mmol/l
2.5
2.4
4.52
168
693
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
481
3504
3.10
25.33
12.2
5.6
u/l
79.9
75.3
1.34
465
3248
(3018010) Neutrophils/100 leukocytes in Blood
339
2089
2.48
25.23
7.1
5.7
%
60.1
57.1
4.18
319
1958
(3006315) Basophils [#/volume] in Blood
353
2218
2.49
25.13
7.0
5.6
e9/l
0.0
0.0
1.93
311
1934
(3013115) Eosinophils [#/volume] in Blood
361
2294
2.50
25.04
7.4
5.7
e9/l
0.2
0.2
3.14
324
2031
(3019198) Lymphocytes [#/volume] in Blood
356
2251
2.49
24.91
7.2
5.6
e9/l
1.6
1.9
1.62
320
2002
(3023368) Bacteria identified in Blood by Culture
230
1223
2.45
23.27
6.0
4.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
314
1932
2.35
22.58
9.8
9.9
inr
1.3
1.3
0.67
104
531
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
342
2219
2.30
21.22
8.9
5.8
mmol/l
1.2
1.2
0.45
284
1913
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
194
992
2.43
21.02
2.7
2.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
35
59
6.25
20.18
1.5
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
42
87
5.12
19.49
1.4
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
314
2012
2.21
19.49
8.4
5.3
mmol/l
1.2
1.2
0.00
293
1804
(3003694) ABO and Rh group [Type] in Blood
207
1120
2.31
19.46
1.4
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
134
597
2.61
19.29
6.1
5.8
mmol/l
1.0
1.0
1.33
124
548
(3007853) Bacteria identified in Skin by Aerobe culture
123
532
2.66
18.76
2.0
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
75
252
3.27
18.02
3.3
1.5
ug/l
33.2
4.0
0.77
61
198
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
101
403
2.82
17.96
1.3
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40
86
4.92
17.78
1.5
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
98
388
2.83
17.67
1.4
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
122
548
2.55
17.11
1.4
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
302
1972
2.10
17.09
12.2
8.5
e9/l
0.0
0.0
0.47
258
1632
(3013826) Glucose [Moles/volume] in Serum or Plasma
383
2792
2.08
15.41
6.5
4.4
mmol/l
6.4
6.8
4.69
363
2603
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
16
14
11.72
15.37
3.4
1.2
nmol/l
2.8
4.1
0.52
16
14
(3018418) pH of Serum or Plasma
214
1267
2.09
15.35
6.1
3.4
ph
7.4
7.4
0.29
58
203
(46235355) HIV 1 and 2 tests - Meaningful Use set
112
515
2.45
14.80
1.5
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
73
278
2.86
14.04
1.8
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
27
54
5.19
13.01
1.5
1.4
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
16
19
8.63
12.42
1.6
1.4
e9/l
1.4
0.2
0.43
16
19
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
12
10
12.23
11.77
1.5
1.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
21
37
5.85
11.55
1.3
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
34
91
3.91
11.45
1.4
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
22
41
5.54
11.43
1.4
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
13
13
10.20
11.37
4.0
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
86
394
2.39
11.31
8.7
7.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
96
466
2.27
11.04
3.3
2.5
umol/l
6.4
8.8
1.18
91
411
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
74
320
2.50
11.03
5.4
3.4
mmol/l
1.2
1.2
1.12
69
276
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
83
380
2.38
10.92
2.6
2.4
ml/min/173m2
60.6
65.0
0.47
25
148
(3017181) Myelocytes/100 leukocytes in Blood
75
328
2.48
10.91
5.3
4.6
%
1.1
0.6
0.77
35
82
(44806118)
23
47
5.05
10.82
1.5
1.5
—
—
—
0
0
(44790047)
23
47
5.05
10.82
1.5
1.5
—
—
—
0
0
(44790049)
23
47
5.05
10.82
1.5
1.5
—
—
—
0
0
(44790048)
23
47
5.05
10.82
1.5
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
72
312
2.49
10.68
5.1
4.7
%
0.1
0.1
0.07
33
75
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
73
4.13
10.61
1.3
1.4
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
12
12
10.19
10.47
1.5
1.7
%
10.5
6.2
0.25
12
12
(21494814) CD8 cells/100 lymphocytes in Specimen
12
12
10.19
10.47
1.5
1.7
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
12
13
9.40
9.90
1.3
1.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
110
589
2.07
9.82
1.6
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
24
56
4.43
9.67
1.3
1.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
17
29
6.01
9.64
1.9
1.8
e9/l
1.4
0.9
0.72
12
17
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
418
3409
1.79
9.10
5.1
3.4
pmol/l
14.5
14.9
1.79
395
3087
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
59
4.20
9.06
1.3
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
14
21
6.81
8.93
1.8
2.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
19
40
4.88
8.64
1.5
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
65
296
2.35
8.63
4.7
4.6
%
0.5
0.3
0.71
22
62
(3036481) Cortisol [Moles/volume] in Serum or Plasma
79
391
2.18
8.60
3.2
1.7
nmol/l
388.8
354.6
0.79
73
360
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
24
62
3.99
8.50
1.3
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
65
299
2.32
8.43
5.4
4.8
%
0.0
1.3
0.50
25
66
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
18
37
4.99
8.41
1.6
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
15
26
5.89
8.36
1.6
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
15
26
5.89
8.36
1.6
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
15
26
5.89
8.36
1.6
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
524
4663
2.19
7.92
25.4
12.7
mg/l
26.0
24.2
0.53
483
3593
(3042111) Morphology [Interpretation] in Bone marrow Narrative
25
71
3.63
7.77
1.9
1.9
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
96
533
1.96
7.66
3.7
2.0
%
1.7
1.7
0.09
87
481
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
18
6.79
7.63
1.2
1.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
18
6.79
7.63
1.2
1.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
22
58
3.90
7.59
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
15
29
5.28
7.48
1.5
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
13
22
6.02
7.41
1.8
2.0
—
16.1
—
0
7
(3005719) IgG [Mass/volume] in Serum or Plasma
65
317
2.18
7.33
3.6
2.1
g/l
9.3
11.1
2.33
58
288
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
119
725
1.81
7.09
3.0
2.9
e6/l
1.6
1.4
0.12
68
403
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
81
435
2.00
7.09
4.5
3.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
14
27
5.29
7.00
1.1
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
116
705
1.81
6.96
2.1
1.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
17
40
4.35
6.79
1.4
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
446
3829
1.69
6.75
29.5
15.5
%
13.9
13.7
2.55
441
3738
(40760892) CBC W Ordered Manual Differential panel - Blood
147
966
1.70
6.69
7.3
4.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
216
1566
1.60
6.66
4.0
3.5
e6/l
76.1
116.3
0.44
154
1118
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
89
512
1.87
6.35
1.9
1.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
23
71
3.33
6.34
1.3
1.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
15
6.77
6.33
3.0
2.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
175
1221
1.62
6.26
3.6
2.9
e6/l
0.2
0.4
2.23
133
910
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
23
72
3.28
6.21
4.3
2.7
%
59.5
58.8
0.08
23
72
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
11
19
5.88
6.12
3.0
1.2
u/l
178.8
200.2
0.64
11
19
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
94
558
1.82
6.06
2.1
2.7
%
23.4
24.4
0.19
83
483
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
23
5.31
6.03
1.2
1.6
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
13
27
4.90
6.00
1.8
1.3
ug/l
21.8
15.2
0.35
13
27
(3002582) Erythrocytes [#/volume] in Urine
188
1352
1.58
5.86
3.7
3.0
e6/l
79.5
116.1
0.20
149
1040
(3031040) Bacteria [#/volume] in Urine by Automated count
351
2893
1.53
5.85
4.2
3.9
e6/l
224.3
1599.9
—
6
51
(3026782) Osmolality of Urine
130
856
1.67
5.80
3.3
2.5
mosm/kgh2o
531.4
566.7
1.01
112
706
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
86
508
1.81
5.63
1.8
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
27
99
2.81
5.60
1.2
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
166
1173
1.58
5.53
3.6
2.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
13
29
4.56
5.53
1.5
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
120
783
1.67
5.52
2.9
2.6
e6/l
0.9
1.0
0.18
69
459
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
48
236
2.13
5.33
1.1
1.2
iu/ml
80.5
153.2
0.84
13
98
(3025941) Bacteria identified in Stool by Culture
44
209
2.20
5.32
1.5
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
406
3491
1.53
5.26
4.9
4.0
mm/h
14.6
11.5
3.61
376
3202
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
42
197
2.22
5.24
3.3
3.4
pmol/l
4.2
4.6
1.85
37
171
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
5
0
+∞
5.21
8.6
0.0
umol/l
0.2
—
—
5
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
21
70
3.07
5.15
4.0
2.4
e9/l
4.9
4.6
0.12
21
70
(3000570) Elastase.pancreatic [Mass/mass] in Stool
28
110
2.62
5.12
1.5
1.4
ug/g
233.4
314.4
0.97
13
63
(40768800) Prostate Pathology biopsy report
16
46
3.55
4.92
1.3
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
95
600
1.70
4.92
2.0
2.6
g/l
2.3
2.3
0.04
88
558
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
20
67
3.06
4.87
1.3
1.5
u/ml
90.7
105.1
—
6
9
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
448
4897
0.64
4.82
4.2
4.8
mmol/l
1.4
1.4
1.57
401
4530
(3019550) Sodium [Moles/volume] in Serum or Plasma
541
5031
2.00
4.81
26.7
15.4
mmol/l
138.9
139.8
8.69
529
4906
(3042631) Mycobacterium sp identified in Specimen
18
57
3.23
4.80
2.2
2.8
—
—
—
0
0
(4281824)
11
24
4.65
4.80
1.2
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
54
289
1.96
4.78
1.4
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
105
691
1.63
4.64
2.2
2.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
499
4546
1.66
4.57
23.3
11.6
ml/min/173m2
81.8
78.9
2.86
443
3681
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
29
123
2.43
4.56
1.6
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
183
1371
1.49
4.53
4.0
2.5
umol/l
2614.8
8078.5
1.31
163
1201
(3023103) Potassium [Moles/volume] in Serum or Plasma
541
5049
1.95
4.48
27.2
15.5
mmol/l
4.0
4.0
3.00
529
4915
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
12
30
4.06
4.45
1.4
1.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
95
617
1.64
4.41
10.3
5.9
mmol/l
103.4
104.2
0.58
90
600
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
189
1446
1.45
4.14
4.1
2.8
u/l
86.8
33.8
0.52
182
1367
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
65
388
1.76
4.11
3.2
2.3
u/l
29.4
48.7
0.95
55
326
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
46
247
1.94
4.06
15.4
10.6
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
7
7
10.10
4.02
3.3
1.3
nmol/l
115.3
73.7
—
7
7
(3044889) 12 lead EKG panel
399
3505
1.44
3.96
4.2
4.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
434
4730
0.68
3.85
3.9
4.3
mmol/l
1.3
1.3
1.92
386
4349
(3023520) Reticulocytes [#/volume] in Blood
65
396
1.72
3.84
4.7
2.2
e9/l
69.0
70.2
0.09
55
313
(3022948) Iron [Moles/volume] in Serum or Plasma
98
664
1.57
3.82
2.3
2.5
umol/l
12.1
13.8
1.43
88
607
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
85
561
1.60
3.70
11.5
7.1
kpa
5.2
5.2
0.20
80
540
(3027801) Oxygen [Partial pressure] in Arterial blood
85
561
1.60
3.70
11.5
7.1
kpa
12.6
11.6
1.07
80
541
(3037756) Immunofixation for Serum or Plasma
18
67
2.74
3.69
2.1
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
209
1662
1.40
3.61
3.6
3.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
133
1757
0.69
3.58
3.5
4.1
mg/mmol
7.7
8.3
0.10
78
1143
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
146
1092
1.45
3.54
2.1
2.1
mg/l
2.6
2.9
0.97
123
928
(3004588) Protein electrophoresis panel - Serum or Plasma
51
297
1.79
3.53
4.5
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
34
173
2.02
3.51
2.1
3.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
36
3.38
3.49
2.8
2.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
460
4934
0.68
3.36
4.3
4.8
mmol/l
4.7
4.5
1.29
418
4579
(3003396) Base excess in Arterial blood by calculation
83
559
1.56
3.32
11.6
7.1
mmol/l
1.5
1.4
0.04
72
436
(3012516) Albumin [Mass/volume] in Urine
126
1662
0.69
3.32
2.9
3.3
mg/l
40.4
155.2
1.24
78
1076
(3009508) Creatinine [Moles/volume] in Urine
132
1724
0.70
3.28
2.8
3.2
mmol/l
8.0
8.2
0.13
106
1453
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
26
123
2.17
3.25
1.2
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
23
104
2.26
3.20
1.7
2.2
%
184.1
200.5
0.34
23
98
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
11
6.42
3.19
1.3
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
11
6.42
3.19
1.0
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
11
6.42
3.19
1.3
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
11
6.42
3.19
1.3
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
11
6.42
3.19
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
26
124
2.15
3.19
1.2
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
433
4684
0.71
3.18
5.2
6.3
mmol/mol
39.3
40.6
2.11
401
4364
(40760888) Immunoglobulin light chains.free panel - Serum
22
98
2.29
3.16
5.8
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
26
125
2.13
3.13
1.2
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
76
509
1.57
3.12
10.8
7.3
%
95.4
95.2
0.10
71
496
(3037467) Urinalysis macro (dipstick) panel - Urine
355
3123
1.35
3.07
4.3
3.9
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
21
93
2.30
3.06
1.5
1.4
u/l
13.0
6.3
1.36
16
80
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
467
4296
1.43
3.03
6.1
4.2
mu/l
2.6
2.3
0.59
442
3898
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
40
3.04
2.98
2.2
2.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
24
114
2.15
2.98
1.5
2.4
g/l
3.9
3.6
0.38
24
106
(40761536) Microorganisms panel - Urine sediment
53
329
1.67
2.96
4.5
3.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
22
4.14
2.89
1.3
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
71
478
1.55
2.86
3.4
3.3
mmol/l
3.2
2.1
1.47
60
393
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
18
4.49
2.80
1.3
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
474
5026
0.70
2.77
4.6
5.4
mmol/l
2.8
2.7
0.80
427
4648
(3000850) Epithelial cells [#/volume] in Urine
123
931
1.41
2.75
3.0
2.2
e6/l
3.5
5.0
0.78
107
809
(3007164) IgA [Mass/volume] in Serum or Plasma
104
765
1.44
2.73
1.9
1.3
g/l
2.4
2.8
1.29
62
453
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
10
6.05
2.70
1.3
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
10
6.05
2.70
1.3
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
10
6.05
2.70
1.3
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
24
120
2.04
2.64
1.5
2.1
%
83.7
88.9
0.51
24
114
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
74
2.34
2.60
1.1
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
33
3.07
2.53
4.3
4.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
10
33
3.07
2.53
1.3
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
39
2.86
2.48
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
11
39
2.86
2.48
1.1
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
89
2.17
2.47
1.1
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
89
2.17
2.47
1.1
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
43
266
1.67
2.46
1.6
1.6
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
6
12
5.04
2.40
4.2
1.1
umol/l
25.8
28.5
—
6
12
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
8
6.29
2.37
2.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
22
3.67
2.37
1.1
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
458
4256
1.35
2.34
25.6
13.8
%
38.6
40.6
4.54
338
2930
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
98
2.08
2.34
2.6
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
50
326
1.58
2.33
3.1
4.2
ng/l
103.6
92.8
0.24
45
285
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
15
65
2.34
2.33
1.1
1.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
34
201
1.73
2.30
2.4
1.5
g/l
1.4
1.4
0.20
28
172
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
34
546
0.60
2.24
1.6
1.5
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
12
48
2.53
2.20
1.5
1.4
g/l
36.6
29.1
1.16
12
41
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
30
3.03
2.15
3.0
2.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
146
1179
1.32
2.14
3.4
2.9
—
—
—
0
0
(3019225) pH of Specimen
64
450
1.47
2.14
3.9
3.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
9
31
2.93
2.08
3.7
2.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
10
5.03
2.07
1.0
1.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
536
5144
1.50
2.00
15.5
9.1
u/l
26.2
27.9
1.95
520
4955
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
11
4.57
1.94
2.8
5.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
10
39
2.59
1.93
1.3
1.4
e6/l
34021.4
199423.7
—
5
25
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
170
1423
1.27
1.88
3.1
2.3
u/l
54.7
58.8
0.77
158
1320
(40761511) CBC panel - Blood by Automated count
518
4954
1.40
1.83
20.2
12.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
342
3111
1.24
1.78
3.5
3.1
u/l
60.6
51.8
0.74
323
2892
(3012501) Base excess in Blood by calculation
17
88
1.96
1.76
3.8
4.9
mmol/l
2.9
3.0
0.01
12
53
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
15
74
2.05
1.76
1.1
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
6
18
3.36
1.75
2.0
1.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
268
0.51
1.74
1.2
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
121
980
1.30
1.73
4.0
4.0
ng/l
661.4
546.2
0.09
103
808
(3051651) Icteric interference index of Serum or Plasma
7
24
2.94
1.72
5.4
4.0
—
—
—
0
0
(3013512) EKG study
174
1475
1.26
1.72
5.0
3.8
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
13
3.87
1.72
2.0
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
29
180
1.64
1.70
1.3
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
7
25
2.82
1.65
1.7
17.7
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
533
5140
1.42
1.61
29.1
14.8
umol/l
80.4
82.0
0.65
533
5140
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
26
2.71
1.58
1.0
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
7
26
2.71
1.58
1.3
1.2
u/l
32.1
39.4
—
7
16
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
114
1.78
1.58
1.6
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
45
315
1.46
1.58
1.1
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
50
2.22
1.57
2.4
1.2
nmol/l
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
23
138
1.69
1.54
7.3
1.3
mg/l
43.3
48.5
0.19
18
112
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
23
139
1.68
1.50
7.3
1.3
mg/l
32.6
36.3
0.12
17
114
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
21
341
0.60
1.50
2.0
2.6
—
13.2
—
0
10
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
203
1777
1.22
1.46
2.2
2.2
nmol/l
79.3
76.7
0.49
185
1558
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
16
3.14
1.44
1.0
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
22
2.74
1.43
1.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
22
2.74
1.43
2.3
3.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
18
103
1.77
1.42
2.2
1.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
49
659
0.72
1.40
4.6
4.8
%
32.7
31.5
0.33
36
445
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
40
2.27
1.40
1.8
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
27
174
1.58
1.39
1.0
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
29
2.43
1.39
1.3
1.2
nmol/l
105.9
154.5
—
7
29
(3039443) Prostate specific Ag panel - Serum or Plasma
8
162
0.49
1.38
1.6
1.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
41
2.21
1.37
5.0
3.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
79
624
1.31
1.37
1.3
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
9
43
2.11
1.30
1.3
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
24
2.52
1.30
1.2
1.0
—
—
—
0
0
(4211845)
6
24
2.52
1.30
2.2
3.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
27
398
0.66
1.29
1.5
1.9
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
36
2.24
1.24
1.6
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
8
36
2.24
1.24
2.8
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
154
1765
0.83
1.23
2.6
3.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
19
116
1.66
1.23
1.1
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
20
124
1.63
1.22
4.9
3.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
20
124
1.63
1.22
2.3
3.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
6
26
2.32
1.19
1.7
2.0
nmol/l
11.8
18.3
—
6
21
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
133
1.60
1.19
2.9
2.7
u/ml
0.4
0.3
0.38
14
73
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
37
266
1.42
1.18
1.3
1.3
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
11
57
1.95
1.17
2.4
1.2
nmol/l
0.5
0.6
1.09
11
51
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
13
72
1.82
1.16
1.2
1.2
u/ml
283.8
310.0
—
8
39
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
35
0.00
1.15
0.0
1.0
—
0.9
—
0
9
(3022621) pH of Urine by Test strip
40
293
1.39
1.15
2.4
2.8
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
36
0.00
1.14
0.0
1.1
—
4.3
—
0
14
(4034850)
11
195
0.56
1.12
6.4
10.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
41
1.96
1.09
1.0
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
126
1083
1.21
1.08
3.2
3.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
26
178
1.48
1.07
3.0
1.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
88
1052
0.81
1.07
4.0
3.7
kg/l
1.0
1.0
0.22
14
137
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
52
1.94
1.06
2.5
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
20
300
0.65
1.06
1.1
1.4
—
54.1
—
0
14
(3001122) Ferritin [Mass/volume] in Serum or Plasma
198
1777
1.17
1.04
2.7
2.7
ug/l
233.3
147.7
2.53
180
1629
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
34
2.07
1.03
1.0
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
158
0.56
0.99
1.1
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
133
1158
1.19
0.99
1.6
1.5
nmol/l
22.5
21.1
0.49
116
984
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
225
2047
1.16
0.99
2.0
2.0
pmol/l
94.3
94.2
0.01
109
1088
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
543
5308
1.32
0.96
34.6
18.6
e9/l
241.9
241.1
0.08
532
5161
(3024731) MCV [Entitic volume]
543
5308
1.32
0.96
34.5
18.6
fl
91.9
91.3
2.11
537
5219
(3009261) Glucose [Presence] in Urine by Test strip
245
2247
1.16
0.96
4.0
3.4
estimate
0.0
0.0
0.00
49
336
(3019832) Treponema pallidum Ab [Presence] in Serum
26
183
1.44
0.95
1.3
1.5
—
—
—
0
0
(3035941) MCH [Entitic mass]
543
5309
1.32
0.95
34.4
18.5
pg
30.6
30.5
0.48
537
5220
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
51
1.78
0.95
1.1
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
51
1.78
0.95
1.0
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
543
5310
1.31
0.94
34.6
18.6
e12/l
4.3
4.6
24.28
531
5148
(3022145) Colonoscopy Study observation
56
448
1.28
0.93
1.4
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
543
5311
1.31
0.93
34.7
18.6
e9/l
6.5
6.7
0.74
531
5151
(3019309) Folate [Moles/volume] in Red Blood Cells
106
911
1.20
0.92
1.8
1.7
nmol/l
1177.1
1147.0
0.11
71
722
(3000963) Hemoglobin [Mass/volume] in Blood
543
5312
1.31
0.92
34.8
18.7
g/l
130.1
139.3
30.66
537
5222
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
101
0.49
0.90
1.6
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
102
0.49
0.90
1.0
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
125
1421
0.85
0.90
1.6
1.6
mmol/l
1.4
1.4
0.09
107
1191
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
113
980
1.19
0.89
1.7
1.7
mg/l
1.4
1.2
0.43
90
753
(3021601) Nitrite [Presence] in Urine by Test strip
240
2213
1.14
0.85
5.3
4.6
estimate
0.0
0.0
0.00
51
355
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
197
2149
0.87
0.81
3.8
3.7
%
21.1
23.4
1.41
88
970
(3017732) Neutrophils [#/volume] in Blood
39
305
1.30
0.79
2.1
2.6
e9/l
4.4
4.1
0.30
31
229
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
29
217
1.35
0.78
8.4
5.4
%
1.6
1.6
0.21
23
211
(3019060) Gas panel - Arterial blood
41
325
1.28
0.75
5.7
5.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
239
2219
1.13
0.75
3.9
3.4
estimate
0.0
0.0
0.00
51
350
(3000330) Specific gravity of Urine by Test strip
31
237
1.33
0.74
4.5
3.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
8
136
0.58
0.73
2.5
1.4
g/l
0.2
0.2
—
8
131
(3004451) EKG impression Narrative
5
25
2.01
0.73
1.8
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
23
168
1.38
0.72
2.2
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
67
788
0.83
0.72
1.3
1.3
iu/ml
24.6
36.3
0.59
24
241
(3013139) Helicobacter pylori Ag [Presence] in Stool
37
292
1.29
0.71
1.1
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
57
1.59
0.71
4.9
5.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
5
26
1.93
0.70
2.2
2.1
—
24.8
—
0
6
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
21
152
1.40
0.70
9.4
7.4
mmol/l
1.1
1.2
0.46
16
139
(40767503) Oxygen content in Capillary blood by calculation
14
93
1.52
0.70
3.1
2.6
%
14.7
16.7
—
7
49
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
272
2554
1.12
0.69
2.8
2.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
69
1.61
0.68
1.1
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
27
1.86
0.68
1.2
2.9
u/ml
698.6
882.6
—
5
27
(3007930) Methemoglobin/Hemoglobin.total in Blood
28
214
1.32
0.68
8.9
5.5
%
1.0
0.9
0.42
23
208
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
95
0.52
0.67
1.0
1.1
u/l
33.9
17.3
—
5
85
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
53
630
0.83
0.64
10.5
6.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
35
435
0.79
0.64
3.3
2.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
138
1519
0.88
0.64
3.0
2.7
ug/l
0.7
0.7
0.10
97
980
(4027681)
5
29
1.73
0.64
1.4
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
417
4026
1.12
0.62
30.1
16.7
g/l
332.7
333.7
1.32
409
4000
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
249
2644
0.90
0.62
4.1
3.8
ug/l
2.1
1.9
0.68
216
2391
(21494434) Karyotype in Bone marrow
8
49
1.64
0.62
1.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
21
157
1.35
0.60
3.3
1.8
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
22
0.00
0.59
0.0
1.1
—
37.6
—
0
12
(3014271) Vancomycin [Susceptibility]
0
23
0.00
0.58
0.0
2.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
53
449
1.20
0.57
1.7
2.3
ug/g
110.9
145.6
0.68
42
367
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
65
745
0.86
0.54
1.3
1.3
u/ml
4.4
12.2
1.23
19
298
(3017446) Testosterone [Moles/volume] in Serum or Plasma
55
471
1.19
0.54
2.0
2.2
nmol/l
14.4
14.9
0.18
47
419
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
93
1035
0.88
0.52
1.5
1.7
pmol/l
472.9
34141133.6
1.19
73
867
(3008898) HLA-B27 [Presence]
9
135
0.66
0.52
1.1
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
15
201
0.74
0.50
1.2
1.8
nmol/l
54.8
41.0
0.75
15
191
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
20
154
1.31
0.49
2.0
1.5
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
7
46
1.53
0.48
1.0
1.3
pmol/l
697.7
66.7
—
7
46
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
47
1.50
0.47
1.9
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
10
68
1.48
0.47
1.0
1.1
g/l
1.5
1.5
—
10
57
(3045414) Leukocytes [Presence] in Urine
24
191
1.27
0.47
2.0
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
48
1.46
0.47
1.9
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
48
1.46
0.47
1.9
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
48
1.46
0.47
1.9
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
48
1.46
0.47
1.9
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
48
1.46
0.47
1.9
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
13
94
1.39
0.46
4.5
3.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
33
394
0.83
0.45
1.2
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
15
112
1.35
0.45
1.3
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
29
239
1.22
0.43
2.2
2.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
78
1.42
0.43
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
56
1.43
0.42
1.4
1.2
—
—
—
0
0
(1002224) Polysomnography panel
16
206
0.77
0.42
1.1
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
15
0.00
0.41
0.0
1.7
—
9.4
—
0
10
(3029075) Extractable nuclear Ab panel - Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
79
1.40
0.41
1.3
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
22
177
1.25
0.41
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
8
60
1.34
0.40
1.0
1.1
%
131.3
113.7
—
8
55
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
60
1.34
0.40
1.1
1.3
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
18
0.00
0.40
0.0
1.1
—
28.7
—
0
13
(3022689) Creatine [Moles/volume] in Urine
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
3.8
—
0
7
(3029937) Albumin [Presence] in Urine by Test strip
128
1189
1.10
0.39
4.4
3.7
estimate
0.0
0.0
0.50
47
337
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
89
1.36
0.38
1.5
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
18
143
1.27
0.37
1.8
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
42
1.43
0.35
2.7
1.2
—
—
—
0
0
(3020891) Body temperature
17
211
0.80
0.35
5.3
4.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
82
1.35
0.34
1.1
1.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
47
1.28
0.32
1.7
2.0
%
10.5
10.4
—
6
47
(3021901) Oxygen saturation in Capillary blood
12
92
1.31
0.32
3.3
2.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
65
591
1.11
0.31
1.6
1.9
%
1.7
1.6
0.38
53
501
(3022313) Gas panel - Capillary blood
28
241
1.17
0.29
3.8
3.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
50
450
1.12
0.29
2.8
3.0
ng/l
243.7
213.4
0.23
42
417
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
39
346
1.14
0.28
1.5
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
30
261
1.16
0.28
3.4
2.6
e6/l
0.1
0.2
0.44
30
255
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
202
1940
1.06
0.27
4.5
3.7
ng/l
34.1
53.1
1.48
165
1401
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
11
139
0.79
0.27
2.0
1.4
g/l
1.2
1.2
0.01
11
133
(1761482) Bacteria [#/volume] in Urine by Culture
15
123
1.23
0.25
6.1
3.9
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
15
123
1.23
0.25
1.5
1.2
u/ml
1.9
2.9
—
5
16
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
78
1.29
0.24
3.8
3.3
—
—
—
0
0
(3000492) Spirometry study
50
457
1.10
0.23
1.4
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
13
106
1.23
0.23
1.4
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
92
868
1.07
0.22
1.3
1.2
u/ml
1.4
1.4
0.01
17
247
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.7
—
15.5
—
0
11
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
10
0.00
0.21
0.0
7.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(4133840)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
38
345
1.11
0.21
3.5
2.9
g/l
124.8
131.0
0.83
38
339
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
23
261
0.88
0.20
1.6
1.7
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
48
1.25
0.20
1.0
1.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
60
1.17
0.18
1.7
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
63
1.11
0.17
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
69
0.72
0.17
1.8
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
72
1.11
0.16
1.6
2.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
160
1560
1.04
0.12
2.6
2.2
u/l
148.4
270.1
1.58
151
1460
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
13
147
0.88
0.11
2.1
2.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
72
691
1.05
0.11
30.8
24.8
inr
1.3
1.3
—
7
106
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
34
318
1.07
0.11
3.6
3.4
mmol/l
3.1
1.9
0.86
27
229
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
27
250
1.08
0.11
2.1
2.3
%
0.6
0.7
0.34
27
244
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
105
1.15
0.11
1.0
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
49
515
0.95
0.10
2.6
2.5
ug/l
7.5
8.6
0.20
39
462
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
168
1714
0.97
0.09
4.5
3.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
47
1.06
0.09
1.0
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
28
262
1.07
0.09
3.7
2.9
mmol/l
26.6
25.2
0.94
28
256
(3041096) Erythrocytes [Presence] in Urine by Automated
118
1152
1.03
0.08
4.5
3.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
56
1.07
0.08
1.5
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
63
0.79
0.08
1.0
1.2
mmol/l
8.1
7.5
—
5
42
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
65
1.08
0.08
1.3
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
65
1.08
0.08
1.4
2.1
—
—
—
0
0
(4306422)
7
67
1.05
0.08
1.0
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
98
1.12
0.07
1.1
1.6
—
—
—
0
0
(4146454)
6
71
0.84
0.07
1.8
2.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
72
0.83
0.07
1.3
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
73
0.82
0.07
1.8
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
77
1.04
0.07
2.8
2.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
17
157
1.09
0.07
6.6
2.7
g/l
0.1
0.2
—
9
58
(3000764) Benzodiazepines [Presence] in Urine
10
89
1.13
0.07
2.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
89
1.13
0.07
2.0
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
100
1.10
0.05
1.1
1.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
17
180
0.94
0.04
1.8
1.6
—
107.5
—
0
8
(4010399)
37
381
0.97
0.03
1.4
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
92
1.09
0.03
2.0
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
10
92
1.09
0.03
2.0
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
182
1.05
0.02
8.4
1.3
g/l
3.7
4.0
0.21
13
130
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
182
1.05
0.02
8.4
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
182
1.05
0.02
8.4
1.3
g/l
6.1
7.4
2.98
14
136
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
105
0.95
0.00
1.2
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
24
236
1.02
0.00
1.4
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
112
0.98
0.00
1.5
1.2
—
—
—
0
0
(4094501)
16
158
1.01
0.00
1.1
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
131
0.99
0.00
1.5
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
60
602
1.00
0.00
1.4
1.3
titre
459.0
459.3
0.00
21
141
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
151
1511
1.00
0.00
3.3
3.0
ng/l
1565.4
1379.3
0.15
134
1284
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
6.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
7
0.00
0.00
0.0
18.6
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025315) Body weight
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
2.8
—
0.2
—
0
5
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
90
1.00
0.00
2.1
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
156.6
—
0
7
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
12.4
—
0
5
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
59
1.02
0.00
3.0
1.8
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
2.3
—
0
9
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
484
4840
1.00
0.00
4.5
4.8
mmol/l
5.9
6.1
2.39
452
4414
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
1.8
—
1.7
—
0
6
(3013762) Body weight Measured
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_TONSIL_EXALLC – Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).